Vir Biotechnology (VIR) Interest & Investment Income (2018 - 2026)

Vir Biotechnology's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 41.5% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $35.1 million (down 44.06% YoY), while the FY2025 annual figure was $40.2 million, down 43.97% from the prior year.
• Interest & Investment Income came in at $7.2 million for Q1 2026 at Vir Biotechnology, down from $7.8 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $21.9 million in Q3 2023 to a low of $7.2 million in Q1 2026.
• A 4-year average of $14.7 million and a median of $14.2 million in 2024 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income declined 20.08% in 2024 and sank 46.58% in 2025, its largest moves.
• Vir Biotechnology's Interest & Investment Income stood at $20.7 million in 2023, then sank by 31.75% to $14.2 million in 2024, then plunged by 44.87% to $7.8 million in 2025, then dropped by 7.86% to $7.2 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $7.2 million, $7.8 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison